An investigation of the expression of FVT-1 (KDSR) in B-cell non-Hodgkin lymphomas [124] found that FVT1 expression by follicular lymphoma did not differ significantly when compared with control tonsil and other types of low-grade B-cell lymphoma (despite the original naming of this gene as a “follicular lymphoma variant”); however, cancer subtypes with lower expression of FVT-1 were correlated with longer survival [124]. This evidence concerns the gene KDSR and B-cell non-Hodgkin lymphoma.